Michael Conte, MD

Co-director of the Heart and Vascular Center

Dr. Michael Conte, a vascular surgeon, is co-director of the UCSF Heart and Vascular Center and chief of Vascular and Endovascular Surgery. He specializes in diseases of the aorta and its major branches, aneurysms, carotid artery disease and peripheral artery disease (PAD). He also treats diabetic vascular disease and performs complex revascularization to preserve limb function and prevent amputation. Conte led the largest multi-center clinical trial to date, examining leg bypass surgery in patients with severe PAD and is studying angioplasty and bypass surgery failure and approaches to identify patients at risk.

Conte earned a medical degree at Albert Einstein College of Medicine in New York City. He completed a surgical residency at New York Hospital-Cornell Medical Center and vascular surgery training as a John Homan's Fellow at Brigham and Women's Hospital in Boston and Harvard Medical School. He is a member of the Society for Vascular Surgery and Society of University Surgeons. In 2006, he received the Distinguished Achievement Award from the New York Weill Cornell Medical Center Alumni Council. He serves on the editorial boards for Vascular and Endovascular Surgery, Vascular Medicine, Journal of Vascular Surgery and Vascular.

Read a Q&A with Conte.


Center for Limb Preservation
400 Parnassus Ave., Room A-501
San Francisco, CA 94143
Phone: (415) 353-2357
Fax: (415) 353-2669

Hours: Monday to Friday
8 a.m. — 5 p.m.

Vascular and Endovascular Surgery
400 Parnassus Ave., Suite 501
San Francisco, CA 94143
Phone: (415) 353-2357
Fax: (415) 353-2669

Hours: Monday to Friday
8 a.m. – 5 p.m.

Vascular Laboratories at Parnassus
505 Parnassus Ave., Eighth Floor, Room M-830A
San Francisco, CA 94143
Phone: (415) 353-1286
Fax: (415) 353-8706

Hours: Monday to Friday
9 a.m. – 5:30 p.m.

Conditions & Treatments

Board Certification

Vascular Surgery, American Board of Surgery

Academic Title


More about Michael Conte

Additional Languages



Albert Einstein College of Medicine 1986


Cornell Medical Center, General Surgery 1993


Brigham and Women's Hospital, Vascular Surgery 1991
Harvard Medical School, Vascular Surgery 1994
Brigham and Women's Hospital, Vascular Surgery 1994

Selected Research and Publications

  1. Conte MS. Data, guidelines, and practice of revascularization for claudication. J Vasc Surg. 2017 Sep; 66(3):911-915.
  2. Ramanan B, Ahmed A, Wu B, Causey MW, Gasper WJ, Vartanian SM, Reyzelman AM, Hiramoto JS, Conte MS. Determinants of midterm functional outcomes, wound healing, and resources used in a hospital-based limb preservation program. J Vasc Surg. 2017 Aug 17.
  3. Wu B, Mottola G, Schaller M, Upchurch GR, Conte MS. Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications. Mol Aspects Med. 2017 Aug 03.
  4. Schaller MS, Zahner GJ, Gasper WJ, Harris WS, Conte MS, Hills NK, Grenon SM. Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements. J Clin Lipidol. 2017 Sep - Oct; 11(5):1289-1295.
  5. Larsen JT, Shanafelt TD, Leis JF, LaPlant B, Call T, Pettinger A, Hanson C, Erlichman C, Habermann TM, Reeder C, Nikcevich D, Bowen D, Conte M, Boysen J, Secreto C, Lesnick C, Tschumper R, Jelinek D, Kay NE, Ding W. Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study. Am J Hematol. 2017 Aug; 92(8):759-763.
  6. O'Banion LA, Wu B, Eichler CM, Reilly LM, Conte MS, Hiramoto JS. Cryopreserved saphenous vein as a last-ditch conduit for limb salvage. J Vasc Surg. 2017 Sep; 66(3):844-849.
  7. Mottola G, Chatterjee A, Wu B, Chen M, Conte MS. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway. PLoS One. 2017; 12(3):e0174936.
  8. Jones WS, Baumgartner I, Hiatt WR, Heizer G, Conte MS, White CJ, Berger JS, Held P, Katona BG, Mahaffey KW, Norgren L, Blomster J, Millegård M, Reist C, Patel MR, Fowkes FG. Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease. Circulation. 2017 Jan 17; 135(3):241-250.
  9. Finnes HD, Chaffee KG, Call TG, Ding W, Kenderian SS, Bowen DA, Conte M, McCullough KB, Merten JA, Bartoo GT, Smith MD, Leis J, Chanan-Khan A, Schwager SM, Slager SL, Kay NE, Shanafelt TD, Parikh SA. Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice. Leuk Lymphoma. 2017 Jun; 58(6):1376-1383.
  10. Baldwin MJ, Policha A, Maldonado T, Hiramoto JS, Honig S, Conte MS, Berger J, Rockman CB. Novel association between bone mineral density scores and the prevalence of peripheral artery disease in both sexes. Vasc Med. 2017 Feb; 22(1):13-20.
  11. De Virgilio A, Greco A, Bussu F, Gallo A, Rosati D, Kim SH, Wang CC, Conte M, Pagliuca G, De Vincentiis M. Salvage total laryngectomy after conservation laryngeal surgery for recurrent laryngeal squamous cell carcinoma. Acta Otorhinolaryngol Ital. 2016 Oct; 36(5):373-380.
  12. Pope NH, Salmon M, Davis JP, Chatterjee A, Su G, Conte MS, Ailawadi G, Upchurch GR. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization. FASEB J. 2016 Dec; 30(12):4192-4201.
  13. Lance KD, Chatterjee A, Wu B, Mottola G, Nuhn H, Lee PP, Sansbury BE, Spite M, Desai TA, Conte MS. Unidirectional and sustained delivery of the proresolving lipid mediator resolvin D1 from a biodegradable thin film device. J Biomed Mater Res A. 2017 Jan; 105(1):31-41.
  14. Strati P, Lanasa M, Call TG, Leis JF, Brander DM, LaPlant BR, Pettinger AM, Ding W, Parikh SA, Hanson CA, Chanan-Khan AA, Bowen DA, Conte M, Kay NE, Shanafelt TD. Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trial. Lancet Haematol. 2016 Sep; 3(9):e407-14.
  15. Ramanan B, Ahmed A, Wu B, Causey MW, Gasper WJ, Vartanian SM, Hiramoto JS, Conte MS. Determinants of Midterm Functional Outcomes and Wound Healing in a Hospital-Based Limb Preservation Program. J Vasc Surg. 2016 Aug; 64(2):546-547.
  16. O'Banion LA, Wu B, Eichler CM, Reilly LM, Conte MS, Hiramoto JS. Cryopreserved Saphenous Vein: Last-Ditch Conduit for Limb Salvage? J Vasc Surg. 2016 Aug; 64(2):546.
  17. Menard MT, Farber A, Assmann SF, Choudhry NK, Conte MS, Creager MA, Dake MD, Jaff MR, Kaufman JA, Powell RJ, Reid DM, Siami FS, Sopko G, White CJ, Rosenfield K. Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial. J Am Heart Assoc. 2016 Jul 08; 5(7).
  18. Causey MW, Ahmed A, Wu B, Gasper WJ, Reyzelman A, Vartanian SM, Hiramoto JS, Conte MS. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program. J Vasc Surg. 2016 Jun; 63(6):1563-1573.e2.
  19. Wu B, Mottola G, Chatterjee A, Lance KD, Chen M, Siguenza IO, Desai TA, Conte MS. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury. J Vasc Surg. 2017 Jan; 65(1):207-217.e3.
  20. Causey MW, Amans MR, Han S, Higashida RT, Conte M. Reversible cerebral vasoconstriction syndrome is a rare cause of stroke after carotid endarterectomy. J Vasc Surg. 2016 Dec; 64(6):1847-1850.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.